GSK plc
Search results
AstraZeneca is a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide.
AstraZeneca's primary listing is on the London Stock Exchange and is a constituent of the FTSE 100 Index; it also has a secondary listing on the Nasdaq Stockholm. AstraZeneca has one of the highest market capitalisations of pharmaceutical companies worldwide.
At AstraZeneca we’re united by our desire to push the boundaries of science to deliver life-changing medicines. We know it’s how we will continue to transform the lives of millions of patients around the world while delivering value to our employees, our communities, and the environment.
Our company. We are a global, science-led, patient-focused pharmaceutical company. We are dedicated to transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet.
To tackle some of the world’s greatest healthcare challenges, we’ve created an inspiring working environment with world-class talent and opportunities. In India, we merge our brightest minds and cutting-edge resources to make a real difference to lives the world over. Search jobs.
AstraZeneca India is a dedicated biopharmaceutical company discovering and developing innovative medicines for life-changing diseases. Learn more about our India chapter and our global edge, here.
Jun 13, 2022 · The AstraZeneca vaccine has an efficacy of 72% against symptomatic SARS-CoV-2 infection, as shown by the primary analysis of data irrespective of interdose interval from trial participants who received 2 standard doses with an interval varying from about 4 to 12 weeks.
• AstraZeneca AB, EU approved nodes [COVID-19 Vaccine (ChAdOx1-S [recombinant])] 10 MAY 2021 UPDATE INCLUDES: • information for interchangeability of ChAdOx1-S/nCoV-19 [recombinant] vaccine products • addition in vaccine effectiveness information in age group 65 and older • information on thrombosis with thrombocytopenia syndrome (TTS)
The Oxford-AstraZeneca vaccine requires two doses, given four weeks apart, to prime the immune system to fight off the coronavirus. During the clinical trial of the vaccine, the researchers...
Latest COVID-19 news and stories. As part of our ongoing efforts against COVID-19, we recognise the crucial need for scientific innovation to stay ahead of the virus, including ongoing research, to enable continued protection, including solutions to protect the most vulnerable populations.
